May 2

High-Yield Pfizer Falls Off The COVID Cliff, And Survives

0 comments

This post was originally published on this site

Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust.

Stop Letting Others Define You — Here’s How to Take Control with a Bold Personal Brand